The Center for Research on Complex Generics (CRCG) facilitates research collaborations that help increase access to safe and effective generic drugs.
CRCG promotes generic industry training and engages the public in complex generics research. Researchers work collaboratively to conduct studies and develop new techniques in complex generics.
AREAS OF EXPERTISE
Faculty conduct drug development research that spans many fields, including complex injectables, drug-device combination products, locally-acting drugs, and quantitative clinical pharmacology.
The University of Maryland, Baltimore and University of Michigan are well-positioned to conduct complex generic drug research that spans from formulation and analytical characterization to clinical studies.
Call for Proposals: In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems
The purpose of this funding opportunity is to develop in vitro test methods for evaluating and comparing the adhesive qualities and adhesion performance of transdermal and topical delivery systems (collectively, TDS) in a manner that can identify the potential for, and mitigate the risk of, differences in TDS adhesion performance in vivo. Differences in product design, formulation (including post-approval changes), or quality attributes between a test (e.g., generic) TDS and its reference TDS may result in differences in product quality and/or performance. The in vitro test methods developed are expected to provide meaningful insights that can assist the development or reformulation of generic TDS, and to support the comparative assessment of whether any differences between a test and reference TDS has the potential to alter the in vivo adhesion performance of a test vs. reference TDS.
CRCG Video Spotlight
Watch this short video to learn more about the Center for Research on Complex Generics.